In another solid tumor commonly reporting IDH1 mutations, flow cytometric, immunohistochemical, and single-cell RNA sequencing analyses have observed that tumors harboring IDH1 mutations may be considered immunologically “cold” compared to wild-type gliomas, given the lower presence of CD8+ T cells and Treg cells [21,22]. Here, IDH1 is linked to central nervous system cancer.